The Diaxxo team has secured an important grant to continue the development of peakPCR, namely the “Bridge proof-of-concept” funding from the Swiss National Science Foundation (SNSF) and Innosuisse – Swiss Innovation Agency.
The grant is valued at 130’000 CHF and will allow us to continuously improve the state of the technology.